ZTS FY 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6.3B+7.5% YoY

Gross Profit

$4.1B65.7% margin

Operating Income

$2.0B32.2% margin

Net Income

$1.5B24.0% margin

EPS (Diluted)

$3.11

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.3B

Stock-Based Comp.

$67M

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$8.8B

Stockholders' Equity

$2.7B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.3B	$5.8B	+7.5%
Gross Profit	$4.1B	$3.8B	+8.3%
Operating Income	$2.0B	$1.9B	+7.3%
Net Income	$1.5B	$1.4B	+5.0%